News for Healthier Living
Dementia risk similar with SGLT2 inhibitors and dulaglutide
A nation-wide, population-based cohort study compared the effects of sodium-glucose cotransporter-2 (SGLT2) inhibitors versus dulaglutide on risk for dementia in older patients with type 2 diabetes (T2D).
August 26, 2024
September 16 2024September 15 2024September 14 2024September 13 2024September 12 2024September 11 2024September 10 2024September 9 2024September 8 2024September 7 2024September 6 2024September 5 2024September 4 2024September 3 2024
|
|
|
|
|